webinar register page

The future of cancer screening
The covid-19 pandemic has amplified structural failings in the access to cancer screening in the UK. Delays in screening and diagnosis have resulted in an increase in the number of patients with late-stage cancers since the start of the pandemic. However, amid a range of new policy and structural developments across the NHS, there remains a strong opportunity to transform cancer screening services by harnessing the power of digital technology.

To discuss the future of cancer screening services, Global Counsel is hosting a panel discussion.

Confirmed speakers are:
- Matthew Swindells, GC Senior Adviser (Chair)
- Professor Dorota Gertig, Medical Director for Population Health, Telstra Health
- Noel Gordon, Chair, Telstra Health UK Strategic Council
- Baroness Delyth Morgan, Chief Executive Officer, Breast Cancer Now
- Maggie Luck, Head of Young Person & Adult Screening at NHS E&I

During the discussion, we will consider:
- The impact of the pandemic on access to cancer screening, and what this has meant for patients and clinicians
- The opportunity of forthcoming NHS structural changes and policy changes (including ICS roll-out and the Health and Care Data Strategy)
- How cancer screening has been transformed in other parts of the world, and what lessons can be learned in the UK

Jul 11, 2022 09:00 AM in London

* Required information